Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026
Same author

Detecting Basilar Artery Wall Pathology in Isolated Pontine Infarction With Short-TE SWI Magnitude Images.

Stroke (Hoboken, N.J.)·2026
Same author

Interpretable machine learning based decision tree model for predicting obstructive airway disease in a large non-smoking health screening population.

Scientific reports·2026
Same author

Early Detection of Dementia Through Spectralis Optical Coherence Tomography in a Taiwanese Cohort.

Diagnostics (Basel, Switzerland)·2026
Same author

Efficient artifact removal for adaptive deep brain stimulation and a temporal event localization analysis.

Journal of neuroscience methods·2026
Same author

Refining postoperative quality metrics: risk factors for emergency department visits within 3 days after hemorrhoidectomy.

Perioperative medicine (London, England)·2025
Same journal

Integrating health economics and implementation science: a call to action.

BMC medical research methodology·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
查看所有相关文章

相关实验视频

Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957

建立一个机器学习痴呆症进展预测模型,使用多个集成数据.

Yung-Chuan Huang1, Tzu-Chi Liu2, Chi-Jie Lu3,4,5,6

  • 1Department of Neurology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.

BMC medical research methodology
|November 23, 2024
PubMed
概括
此摘要是机器生成的。

机器学习使用临床和实验室数据准确预测痴呆症进展. XGBoost模型确定了八个关键变量,为管理退行性痴呆症提供了有价值的临床指导.

关键词:
痴呆症是一种痴呆症.极端的梯度增强了极端的梯度.机器学习是机器学习.预测模型的预测模型.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K

相关实验视频

Last Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K

科学领域:

  • 神经学 神经学
  • 人工智能的人工智能
  • 数据科学数据科学数据科学

背景情况:

  • 痴呆症是一个重大的全球健康挑战,需要有效的工具来预测疾病的进展.
  • 机器学习 (ML) 提供了一种强大的方法,可以从复杂的现实世界临床数据中开发预测模型.

研究的目的:

  • 开发和验证用于预测退行性痴呆症进展的机器学习模型.
  • 确定最能预测痴呆症进展的关键临床和人口学变量.

主要方法:

  • 对679名患有退行性痴呆症的患者进行了回顾性分析,追踪时间超过两年.
  • 使用极端梯度增强 (XGB) 模型分析人口统计,临床痴呆评级 (CDR),迷你精神状态检查 (MMSE) 和实验室数据 (LV) 变量.
  • 采用一步一步的方法来确定最佳的特征组合和变量重要性.

主要成果:

  • 集成的D-CDR-MMSE-LV模型在接收器操作特征曲线 (AUC) 下实现了高面积的85.12.
  • XGBoost模型从集成的数据集中确定了八个关键变量.
  • 该模型表现出强大的性能与高灵敏度 (84.66).

结论:

  • 成功开发了一种机器学习模型,使用现实世界的临床数据来监测痴呆症的进展.
  • 确定了八个关键变量,为临床医生提供了指导痴呆症患者管理的宝贵见解.